US20180008336A1

US20180008336A1 - Systems and methods for treating tissue with radiofrequency energy

Info

Publication number: US20180008336A1
Application number: US15/713,591
Authority: US
Inventors: Oleg Shikhman; Ronald L. Green; Jeffrey Radziunas
Original assignee: Mederi Therapeutics Inc
Current assignee: Mederi Rf LLC; Horizon Credit II LLC
Priority date: 2009-09-22
Filing date: 2017-09-22
Publication date: 2018-01-11
Also published as: US9775664B2; US20150366604A1

Abstract

A device for applying radiofrequency energy for sphincter treatment comprising a flexible outer tube, an expandable basket having a plurality of arms movable from a collapsed position to an expanded position, and a plurality of electrodes movable with respect to the arms from a retracted position to an extended position. An advancer is slidably disposed within the outer tube to move the plurality of electrodes to the extended position. An actuator moves the advancer from a first position to a second position to advance the plurality of electrodes. An aspiration tube extends within the outer tube. An assembly includes an aspiration disabler having a first position to enable aspiration from a distal portion of the aspiration tube to a proximal portion and a second position to disable aspiration.

Description

RELATED APPLICATIONS

This application claims the benefit of provisional application Ser. No. 62/050,090, filed Sep. 13, 2014, and is a continuation-in-part of application Ser. No. 14/708,209, filed May 9, 2015 which claims the benefit of provisional application Ser. No. 62/009,222, filed Jun. 7, 2014, and is a continuation-in-part of application Ser. No. 13/867,042, filed Apr. 20, 2013, which claims the benefit of provisional application Ser. No. 61/664,960, filed Jun. 27, 2012, and is a continuation-in-part of application Ser. No. 12/924,155, filed Sep. 22, 2010, which claims the benefit of provisional application Ser. No. 61/277,260, filed Sep. 22, 2009. The entire contents of each of these applications are incorporated herein by reference.

FIELD OF THE INVENTION

In a general sense, the invention is directed to systems and methods for treating interior tissue regions of the body. More specifically, the invention is directed to systems and methods for treating dysfunction in body sphincters and adjoining tissue by applying radiofrequency energy to tissue to create tissue lesions without ablating tissue.

BACKGROUND OF THE INVENTION

The gastrointestinal (GI) tract, also called the alimentary canal, is a long tube through which food is taken into the body and digested. The alimentary canal begins at the mouth, and includes the pharynx, esophagus, stomach, small and large intestines, and rectum. In human beings, this passage is about 30 feet (9 meters) long.
Small, ring-like muscles, called sphincters, surround portions of the alimentary canal. In a healthy person, these muscles contract or tighten in a coordinated fashion during eating and the ensuing digestive process, to temporarily close off one region of the alimentary canal from another region of the alimentary canal.
For example, a muscular ring called the lower esophageal sphincter (or LES) surrounds the opening between the esophagus and the stomach. Normally, the lower esophageal sphincter maintains a high-pressure zone between fifteen and thirty mm Hg above intragastric pressures inside the stomach.
In the rectum, two muscular rings, called the internal and external sphincter muscles, normally keep fecal material from leaving the anal canal. The external sphincter muscle is a voluntary muscle, and the internal sphincter muscle is an involuntary muscle. Together, by voluntary and involuntary action, these muscles normally contract to keep fecal material in the anal canal.
Dysfunction of a sphincter in the body can lead to internal damage or disease, discomfort, or otherwise adversely affect the quality of life. For example, if the lower esophageal sphincter fails to function properly, stomach acid may rise back into the esophagus. Heartburn or other disease symptoms, including damage to the esophagus, can occur. Gastrointestinal reflux disease (GERD) is a common disorder, characterized by spontaneous relaxation of the lower esophageal sphincter.
Damage to the external or internal sphincter muscles in the rectum can cause these sphincters to dysfunction or otherwise lose their tone, such that they can no longer sustain the essential fecal holding action. Fecal incontinence results, as fecal material can descend through the anal canal without warning, stimulating the sudden urge to defecate. The physical effects of fecal incontinence (i.e., the loss of normal control of the bowels and gas, liquid, and solid stool leakage from the rectum at unexpected times) can also cause embarrassment, shame, and a loss of confidence, and can further lead to mental depression.
In certain surgical systems, radiofrequency energy is applied to tissue at different tissue levels to create multiple tissue lesions. Application of such energy requires continuous monitoring of certain tissue and/or device parameters to ensure that the tissue is not heated to such extent that damaging burning of tissue occurs. Thus, these systems monitor tissue temperature and/or device electrode temperature and provide safety features to cut off energy flow if the tissue temperature rises too high. However, with the application of radiofrequency energy, there is a fine point in which tissue is treated to form lesions and beneficially alter structure of the tissue, e.g., alter the structure of the sphincter muscle, while not being ablated.
Ablation of tissue can be generally defined as a removal of a part of tissue. Radiofrequency energy to ablate tissue has been used for various tumor treatments, destroying tissue and creating tissue necrosis. However, avoiding tissue ablation may be beneficial in treating the gastrointestinal tract in the foregoing or other procedures. Therefore, it would be advantageous to provide a system of applying radiofrequency energy to tissue at a power setting and time duration which causes thermal effect to tissue to create tissue lesions along a series of tissue levels but avoids ablation or burning of tissue.
However, in avoiding tissue ablation, care needs to be taken to ensure that tissue is not undertreated. In other words, in attempts to prevent overheating of tissue which causes ablation, the system needs to conversely ensure that tissue is not under-heated and thus not therapeutically treated. Therefore, the need exists for a system that applies radiofrequency energy to tissue between these two energy levels.

SUMMARY OF THE INVENTION

The present invention advantageously provides an electrosurgical system that applies radiofrequency energy to tissue to create tissue lesions at different tissue levels and alters the structure of the tissue, e.g., the sphincter muscle, without ablating or burning the tissue, while on the other hand reducing the incidence of tissue undertreatment. That is, the present invention advantageously provides such electrosurgical system that avoids such overheating of tissue, while at the same time limiting under-heating of tissue which does not effectively treat tissue. Thus, in striking this balance between the overheating and under heating of tissue, more reliable and consistent tissue treatment is achieved.
This prevention of overtreatment and undertreatment are achieved in various ways. The below described different aspects utilized to achieve the desired tissue treatment can be implemented alone or in combination with each other.
Thus, the system and method of the present invention advantageously keeps tissue treatment within a target zone to provide a therapeutic effect to tissue, defined as thermally heating tissue above a lower parameter wherein tissue is undertreated and below a tissue ablation threshold wherein tissue is overheated and ablated.
The present invention in accordance with one aspect provides an assembly for disabling suction. In one aspect, a device for applying radiofrequency energy for sphincter treatment is provided comprising a flexible outer tube, an expandable basket having a plurality of arms movable from a collapsed position to an expanded position, and an opening in the arms. A plurality of electrodes are movable with respect to the arms from a retracted position to an extended position to extend through the openings in the arms. An advancer is slidably disposed within the outer tube, and the plurality of electrodes are operably coupled to the advancer such that movement of the advancer advances the plurality of electrodes through the openings to the extended position. An actuator for moving the advancer from a first position to a second position to advance the plurality of electrodes is provided. An aspiration tube extends within the outer tube and an assembly for disabling aspiration (suction) through the aspiration tube includes a disabler having a first position to enable aspiration from a distal portion of the aspiration tube to a proximal portion, the disabler movable to a second position to disable aspiration.
In some embodiments, the disabler includes a sliding mechanism movable between first and second positions, wherein in the first position of the sliding mechanism, an opening in the aspiration tube is closed to enable aspiration and in the second position of the sliding mechanism the opening is open to disable aspiration. In some embodiments, the opening is in a sidewall of the aspiration tube.
In some embodiments, the sliding mechanism is connected to a pivotable linkage, wherein movement of the sliding mechanism pivots the linkage to open and close the opening in the aspiration tube. In other embodiments, the disabler includes a mechanism movable transverse to a longitudinal axis of the aspiration tube between outer an inner positions, wherein in the outer position of the mechanism an opening in the aspiration tube is closed to enable aspiration and in the inner position of the mechanism the opening in the aspiration tube is open to disable aspiration, the inner position defined as the mechanism positioned further into a longitudinal lumen of the aspiration tube. In other embodiments, the disabler includes a mechanism pivotable with respect to the aspiration tube, wherein in a first position of the mechanism a longitudinally extending lumen of the aspiration tube is open to enable aspiration and in a second position of the mechanism the longitudinally extending lumen of the aspiration tube is closed to disable aspiration, the mechanism having an engagement surface to apply a force to and deform a wall of the aspiration tube to close the longitudinally extending lumen.
In some embodiments, the disabler includes a mechanism pivotable between the first and second positions. In other embodiments, the mechanism is slidable transverse to the longitudinal axis of the aspiration tube to move between the first and second position.
The mechanism can be biased to the first position or the second position.
In some embodiments, the mechanism includes a retention locking feature to lock the mechanism in the inner and/or outer position.
In some embodiments, the device further comprises an elongated spacer positioned within the outer tube, the spacer having a central lumen to receive the advancer and to maintain a central position of the advancer. The spacer can have a rib extending from a wall defining the central lumen to an inner wall of the spacer. The spacer can have a slit forming a flap which is elongated and extends longitudinally along at least a portion of the spacer. The flap can be openable progressively to progressively lay the wires within the spacer. In some embodiments, the spacer is more rigid than the outer tube such that the outer tube can be formed of a more flexible material than if the spacer was not provided.
The spacer, if provided, can include an outer wall having at least one longitudinally extending slit formed therein, the slit being separable to provide access to an interior of the spacer for placement of a plurality of wires within the interior of the spacer and for placement of one or both of an irrigation tube or aspiration tube within the interior of the spacer. In some embodiments, the spacer includes a plurality of transverse ribs to form separate internal regions of the spacer and a plurality of longitudinally extending slits are formed in the outer wall of the spacer to provide access to each of the internal regions.
In some embodiments, the plurality of electrodes include a location feature engageable with an electrode holder to maintain radial spacing of the electrodes. In some embodiments, the arms have an alignment feature engageable with an arm holder to maintain alignment of the arms. Preferably, the location feature maintains an equidistant spacing of the distal tips of the electrodes.
In some embodiments, the electrodes include a substantially conical non-penetrating tip.
In accordance with another aspect of the present invention, a system for controlling operation of a radiofrequency treatment device to apply radiofrequency energy to tissue to heat tissue to create tissue lesions without ablating the tissue is provided comprising a treatment device having a plurality of electrodes for applying radiofrequency energy to tissue. The treatment device further includes an assembly having a disabler for disabling aspiration (suction) through an aspiration tube extending through the device, the disabler having a first position to enable aspiration from a distal portion of the aspiration tube to a proximal portion of the aspiration tube, the disabler movable to a second position to disable aspiration. A controller includes a connector to which the treatment device is coupled for use, and a generator for applying radiofrequency energy to the plurality of electrodes is provided.
The system can further include a controller including an operation system to execute on a display screen a first graphical interface guiding use of the treatment device, the controller visually prompting a user in a step-wise fashion to perform a process using the connected treatment device of forming a pattern of lesions in a body region in a plurality of axially spaced lesion levels, each lesion level including a plurality of circumferential spaced lesions. The controller controls application of energy so that the tissue is thermally treated to create lesions but preventing thermal treatment beyond a threshold which would ablate the tissue.
In some embodiments, the device further comprises a spacer, the spacer having a plurality of separable portions for placement of components within different sections of an interior of the spacer.
In some embodiments, the plurality of electrodes include a location feature engageable with an electrode holder to maintain radial spacing of the electrodes. The location feature maintains an equidistant spacing of the distal tips of the electrodes.
The present invention in accordance with another aspect provides a method of treating gastrointestinal reflux disease comprising:
providing a treatment device having a plurality of electrodes and an assembly having a disabler for disabling aspiration (suction) through the aspiration tube, the disabler having a first position to enable aspiration from a distal portion of the aspiration tube to a proximal portion of the aspiration tube, the disabler movable to a second position to disable aspiration to facilitate axial and rotational movement of the treatment device within tissue and limit undesired movement of tissue;
applying radiofrequency energy to the plurality of electrodes to thermally treat tissue below a tissue ablation threshold and create a plurality of tissue lesions along axially spaced tissue levels within the upper gastrointestinal tract;
monitoring tissue temperature throughout the procedure; and
regulating power ensuring in response to the monitoring step that the tissue temperature does not exceed a predetermined value which would cause tissue ablation and/or tissue necrosis.
In some embodiments, the method further comprises the step of sliding a mechanism to selectively cover and uncover an opening in a sidewall of the aspiration tube. In some embodiments, the step of sliding a mechanism slides the mechanism axially. The method may further include the step of moving a mechanism radially inwardly to deform a wall of the aspiration tube.
Further features and advantages of the inventions are set forth in the following Description and Drawings, as well as in the appended claims.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1A is a schematic view of one embodiment of a system for use with the device of the present invention;

FIG. 1B is a perspective view of one embodiment of an integrated device incorporating features of the system shown in FIG. 1;

FIG. 1C is a perspective view of another embodiment of an integrated device incorporating features of the system shown in FIG. 1;

FIG. 2A is an isometric view of a first embodiment of the device of the present invention shown with the basket in the non-expanded position;

FIG. 2B is an isometric view of the device of FIG. 2A shown with the basket in the expanded position and the electrodes in the advanced (deployed) position;

FIG. 3 is an exploded isometric view of the proximal region of the device of FIG. 1;

FIG. 4 is an exploded isometric view of the distal region of the device of FIG. 1;

FIG. 5 is a side view with a portion of the housing removed to illustrate the internal components within the handle section and a proximal portion of the spacer with the clamp;

FIG. 6 is a side view of a portion of the housing removed to illustrate the internal components within the handle section and the proximal portion of the spacer, the clamp removed for clarity;

FIG. 7 is an isometric view of the spacer of the present invention;

FIG. 8A is front view of the spacer shown with the wires positioned therein;

FIG. 8B is a front view of an alternate embodiment of the spacer;

FIG. 9 is a side perspective view showing the wires being inserted into the spacer during a manufacturing step;

FIGS. 10 and 11 are isometric and side cross-sectional views, respectively, of the spacer;

FIG. 12 is a side view of an alternate embodiment of the spacer of the present invention;

FIG. 13 is an enlarged isometric cross-sectional view of a distal portion of the spacer of FIG. 7;

FIG. 14 is a view similar to FIG. 13 showing the holder and clamp;

FIG. 15 is a view similar to FIG. 13 showing the holder, clamp and irrigation tube;

FIGS. 16 and 17 are front and back isometric views, respectively, of the irrigation manifold;

FIG. 18 is a side view of the irrigation manifold of FIG. 16 with the basket arms inserted;

FIG. 19 is a side view of the needle electrode of the present invention;

FIG. 20 is a top view of the needle electrode of FIG. 19;

FIG. 21 is an enlarged view of the location feature of the electrode needle of FIG. 19;

FIG. 22 is an isometric view of the needle holder;

FIG. 23A is an isometric view showing the needle electrode of FIG. 19 being inserted into the needle holder of FIG. 23;

FIG. 23B is an isometric view similar to FIG. 23A showing the needle electrode positioned in the needle holder;

FIG. 24 is an isometric view illustrating the four needle electrodes positioned in the needle holder of FIG. 22;

FIG. 25 is a close up view of the needle holder and sleeve;

FIG. 26 is a view similar to FIG. 25 showing the tube clamp over the needle holder sleeve;

FIG. 27 is a top view of one of the basket arms (spines);

FIG. 28 is an enlarged view of the area of detail identified in FIG. 27;

FIG. 29 is a bottom view of the basket arm of FIG. 27;

FIG. 30A is an isometric view of one of the basket arms being inserted into the basket holder;

FIG. 30B illustrates the opposing side of the basket arm and basket holder of FIG. 30A;

FIG. 30C is a cross-sectional view illustrating an alternate embodiment and showing the four arm channels engaged with the basket holder;

FIG. 31 is a front view in partial cross-section showing the basket arm of FIG. 30A engaged within the basket holder;

FIG. 32 is a side view showing the basket arms positioned in the basket holder;

FIG. 33 is a front view showing all four basket arms positioned in the basket holder;

FIG. 34A is a front view of the device of FIG. 1 with the needle electrode in the deployed (advanced) position illustrating radial alignment of the needle tips;

FIG. 34B is a side view of the basket and needle electrodes in the deployed position illustrating radial and longitudinal alignment of the needle electrode tips;

FIGS. 35A and 35B illustrate what occurs if the needle electrode tips are not radially aligned;

FIG. 35C illustrates what occurs if the needle electrode tips are not longitudinally aligned;

FIGS. 36-38 illustrate the method of use of the device of FIG. 2A wherein FIG. 36 shows the device inserted within a sphincter in the non-expanded condition; FIG. 37 shows the basket expanded to dilate the sphincter wall, and FIG. 38 shows the needles deployed to penetrate tissue;

FIG. 39 illustrates the desired formation of lesions utilizing the aligned needle and basket assembly features of the present invention;

FIG. 40 is a side view of a proximal portion of the apparatus showing one embodiment of the aspiration (suction) disabling assembly of the present invention;

FIG. 41A is a longitudinal cross-sectional view of a first embodiment of the suction disabling assembly of the present invention, the assembly shown in the closed position to enable suction;

FIG. 41B is a view similar to FIG. 40 showing the suction disabling assembly in the open position to disable suction;

FIG. 41C is a perspective view of the suction disabling assembly of FIG. 41A;

FIG. 41D is an exploded view of the suction disabling assembly of FIG. 41A;

FIG. 42A is longitudinal cross-sectional view of a second embodiment of the suction disabling assembly of the present invention, the assembly shown in the closed position to enable suction;

FIG. 42B is a view similar to FIG. 42A showing the suction disabling assembly in the open position to disable suction;

FIG. 43A is longitudinal cross-sectional view of a third embodiment of the suction disabling assembly of the present invention, the assembly shown in the closed position to enable suction;

FIG. 43B is a view similar to FIG. 43A showing the suction disabling assembly in the open position to disable suction;

FIG. 44A is longitudinal cross-sectional view of a fourth embodiment of the suction disabling assembly of the present invention, the assembly shown in a first position to enable suction;

FIG. 44B is a view similar to FIG. 44A showing the suction disabling assembly in a second position to disable suction;

FIG. 45A is longitudinal cross-sectional view of a fifth embodiment of the suction disabling assembly of the present invention, the assembly shown in the first position to enable suction;

FIG. 45B is a view similar to FIG. 45A showing the suction disabling assembly in the closed position to disable suction;

FIG. 46A is longitudinal cross-sectional view of a sixth embodiment of the suction disabling assembly of the present invention, the assembly shown in the open position to enable suction;

FIG. 46B is a view similar to FIG. 46A showing the suction disabling assembly in the closed position to disable suction; and

FIG. 47 is a side view of an alternate embodiment of the electrode tip; and

FIG. 48 is a close up view of the electrode tip of FIG. 48 in contact with tissue.

The invention may be embodied in several forms without departing from its spirit or essential characteristics. The scope of the invention is defined in the appended claims, rather than in the specific description preceding them. All embodiments that fall within the meaning and range of equivalency of the claims are therefore intended to be embraced by the claims.

DESCRIPTION OF PREFERRED EMBODIMENTS

This specification discloses various systems and methods for treating dysfunction of sphincters and adjoining tissue regions in the body. The systems and methods are particularly well suited for treating these dysfunctions in the upper gastrointestinal tract, e.g., gastro-esophageal reflux disease (GERD) affecting the lower esophageal sphincter and adjacent cardia of the stomach. For this reason, the systems and methods will be described in this context. Still, it should be appreciated that the disclosed systems and methods are applicable for use in treating other dysfunctions elsewhere in the body, including dysfunctions that are not necessarily sphincter-related. For example, the various aspects of the invention have application in procedures requiring treatment of hemorrhoids, or fecal incontinence, or urinary incontinence, or restoring compliance to or otherwise tightening interior tissue or muscle regions. The systems and methods that embody features of the invention are also adaptable for use with systems and surgical techniques that are catheter-based and not necessarily catheter-based.
The systems and methods disclosed herein provide application of radiofrequency energy to tissue via a plurality of electrodes. The energy is applied via the electrodes to tissue at a series of axially spaced tissue levels, thereby forming tissue lesions which alters the tissue structure. Prior application of radiofrequency energy to tissue in various surgical procedures involved application of energy at certain levels and for a certain period of time with the goal to ablate the tissue. That is, the objective was to cause tissue necrosis and remove tissue. The systems and methods of the present disclosure, however, treat tissue without ablating the tissue and without causing tissue necrosis, which advantageously achieves better clinical results, especially when treating the sphincter muscles of the GI tract in the specific surgical procedures disclosed herein. By applying sufficient energy to cause thermal effect to tissue, but without ablating or burning the tissue, tissue reconstruction/remodeling occurs which results in beneficial changes to tissue properties, thus beneficially treating GERD which is caused by the spontaneous relaxation of the lower esophageal sphincter and beneficially treating fecal incontinence caused by loss of tone of the sphincter muscles in the anal canal. The system of the present disclosure rejuvenates muscle to improve muscle function. The system of the present invention also increases the smooth muscle/connective ratio which results in sphincter reinforcement and remodeling.
In studies performed, it was found that application of non-ablative RF energy to sphincter muscle influences the structural arrangement of smooth muscle and connective tissue contents. The increase of the smooth muscle fibers area per muscle bundles as well as the collagen and myofibroblast contents within the internal anal sphincter were found to be potentially responsible for sphincter reinforcement and remodeling. More specifically, in studies, it was found that application of non-ablative RF energy increased smooth muscle/connective tissue ratio without changes (increase) in the collagen I/III ratio. There was an increase in diameter and number of type I fibers in the external anal sphincter after non-ablative RF and higher cellular smooth muscle content in the internal anal sphincter, suggesting that sphincter remodeling by non-ablative RF energy resulted from activation and repopulation of smooth muscle cells, possibly related to phenotype switch of fibroblasts into myofibroblasts and external anal sphincter fibers. In one animal study, quantitative image analysis showed the cross-section occupied by smooth muscle within the circular muscle increased by up to 16% after non-ablative RF, without increase in collagen I/III ratio, and external anal sphincter muscle fiber type composition showed an increase in type I/III fiber ratio from 26.2% to 34.6% after non-ablative RF, as well as a 20% increase in fiber I type diameter compared to controls.
For such aforedescribed non-ablation RF treatment, the system and method of the present disclosure ensure proper radial and longitudinal (axial) alignment of the tips of the needle electrodes. This can prevent overheating of tissue since the equidistantly spaced electrodes ensure there is no undesired overlap of tissue treatment regions which could occur if the tips were not equally radially spaced. This is especially the case since the device in use is rotated to treat lesions at the same axial lesion level and moved longitudinally to treat tissue at different axial lesion levels. Such radial spacing and longitudinal alignment also ensures that tissue is not undertreated which could occur if spacing between the needle tips is too great and therefore areas of tissue are not properly treated. Furthermore, the longitudinal spacing ensures that tissue is not overheated or underheated due to undesired variations of tissue penetration/depth of energy application, compounded due to rotation and longitudinal repositioning of the device. This is discussed in more detail below.
Various features of the surgical treatment devices connected to the controller achieve the foregoing. Preventing overheating of tissue is achieved by enhanced temperature control of the tissue, which is accomplished in one way by more accurate needle tip alignment, more accurate basket alignment, and/or maintaining centering of the needle advancer during flexing of the catheter to maintain a desired depth of penetration during bending of the device.
FIG. 1A shows a unified system for diagnosing and/or treating dysfunction of sphincters and adjoining tissue in the body. The targeted sphincter regions can vary. In the illustrated embodiment, one region comprises the upper gastro-intestinal tract, e.g., the lower esophageal sphincter and adjacent cardia of the stomach. Other regions are also contemplated.
In the illustrated embodiment, the device 10 of FIGS. 2A and 2B function in the system to apply energy in a selective fashion to tissue in or adjoining the targeted sphincter region. The applied energy creates one or more lesions, or a prescribed pattern of lesions, below the surface of the targeted region without ablating tissue. The subsurface lesions are desirably formed in a manner that preserves and protects the surface against thermal damage. Preferably, the energy is applied to the muscle layer, beyond the mucosa layer.
Natural healing of the subsurface lesions leads to a reconstruction/remodeling of the tissue which leads to beneficial changes in properties of the targeted tissue. The subsurface lesions can also result in the interruption of aberrant electrical pathways that may cause spontaneous sphincter relaxation. In any event, the treatment can restore normal closure function to the sphincter region as the non-ablating application of radiofrequency energy beneficially changes the properties of the sphincter muscle wall. Such energy rejuvenates the muscle to improve muscle function.
With reference to FIG. 1A, the system 2 includes a generator 4 to supply the treatment energy to the device 10. In the illustrated embodiment, the generator 4 supplies radio frequency energy, e.g., having a frequency in the range of about 400 kHz to about 10 mHz, although other ranges are contemplated. Other forms of energy can be applied, e.g., coherent or incoherent light; heated or cooled fluid; resistive heating; microwave; ultrasound; a tissue ablation fluid; or cryogenic fluid. Device 10 is coupled to the generator 4 via a cable connector 5 to convey the generated energy to the respective device 10.
The system preferably also includes certain auxiliary processing equipment. In the illustrated embodiment, the processing equipment includes an external fluid delivery apparatus 6 and an external aspiration apparatus 8.
Device 10 can be connected via tubing 6 a to the fluid delivery apparatus 6 to convey processing fluid for discharge by or near the device 10. Device 10 can also be connected via tubing 8 a to the aspirating apparatus 8 to convey aspirated material by or near the device for removal.
The system also includes a controller 9. The controller 9, which preferably includes a central processing unit (CPU), is linked to the generator 4, and can be linked to the fluid delivery apparatus 6, and the aspiration apparatus 8. Alternatively, the aspiration apparatus 8 can comprise a conventional vacuum source typically present in a physician's suite, which operates continuously, independent of the controller 9.
The controller 9 governs the power levels, cycles, and duration that the radio frequency energy is distributed to the device 10 to achieve and maintain power levels appropriate to achieve the desired treatment objectives. In tandem, the controller 9 also desirably governs the delivery of processing fluid and, if desired, the removal of aspirated material. Thus, the controller maintains the target tissue temperature to ensure the tissue is not overheated.
The controller 9 includes an input/output (I/O) device 7. The I/O device 7 allows the physician to input control and processing variables, to enable the controller to generate appropriate command signals. The I/O device 7 also receives real time processing feedback information from one or more sensors associated with the operative element (as will be described later), for processing by the controller 9 e.g., to govern the application of energy and the delivery of processing fluid. The I/O device 7 also includes a graphical user interface (GUI), to graphically present processing information to the physician for viewing or analysis.
In an alternate embodiment of FIG. 1B, the radio frequency generator, the controller with I/O device, and the fluid delivery apparatus (e.g., for the delivery of cooling liquid) are integrated within a single housing 200. The I/O device 210 couples the controller to a display microprocessor 214. The display microprocessor 214 is coupled to a graphics display monitor 216 in the housing 200. The controller 212 implements through the display microprocessor 214 the graphical user interface, or GUI, which is displayed on the display monitor 216. The graphical user interface can be realized with conventional graphics software using the MS WINDOWS® application. The GUI is implemented by showing on the monitor 216 basic screen displays.
FIGS. 1C illustrates another embodiment where the radio frequency generator, the controller with I/O device, and the fluid delivery control apparatus (e.g., for the delivery of cooling liquid) are integrated within a single housing 200 a. Connection port 209 is for connecting the treatment device.
Turning now to the treatment device of the present invention, in general, the device 10 is a catheter-based device for treating sphincter regions in the upper gastro-intestinal tract, and more particularly, the lower esophageal sphincter and adjoining cardia of the stomach to treat GERD. In the embodiment shown, the device 10 includes a flexible catheter tube 22 that has a handle 16 at its proximal end. The distal end of the catheter tube 22 carries the operative element. Note that for clarity throughout the drawings not all identical components are labeled in the specific drawing.
With reference to FIGS. 2A-4, wherein like reference numerals refer to like parts throughout the several views, device 10 has a proximal portion 12, a distal portion 14 and an elongated flexible outer catheter tube 22. Contained within the outer tube 22 is spacer 40 discussed in more detail below. The basket assembly is designated generally by reference numeral 18 and is movable between a collapsed position (configuration) to provide a reduced profile for delivery and an expanded position (configuration) to dilate the tissue, e.g., the sphincter wall. The basket assembly 18 includes a balloon 80 (FIG. 4) which is inflated via inflation portion 30 extending from handle 16 to expand the basket 18.
Also extending from handle 16 is an aspiration port 26 to enable aspiration through the device 10 and an irrigation port 28 to enable fluid injection through the device 10.
The device 10 also includes a plurality of needle electrodes 32 which are movable from a retracted position for delivery to an advanced position protruding through the basket for penetrating tissue. Plug 29 extends from handle 16 and electrically communicates with a generator to apply radiofrequency to the electrodes 32 for application of such energy to treat tissue as discussed in more detail below. Slider 24 on handle 16 is one type of mechanism that can be used to advance the needle electrodes 32. In this mechanism, slider 24 is movable from an initial position of FIG. 2A to a second advanced position of FIG. 2B to advance the electrodes 32. Such advancement is achieved as rod 33 (FIG. 3) is attached to the slider 24 at one end and the other end is attached to needle pusher 42. A proximal end of the needle electrodes 32 are coupled to a distal end of the needle pusher (advancer) 42. Rod 33 can include a calibration nut 33 a.
As used herein, attached or coupled is not limited to direct attachment as interposing components can be used.
Spacer 40 is positioned within outer tube 22 and functions to separate the various internal components and maintain a center position of needle advancer 42. Needle advancer 42 is slidably positioned within a central lumen of the spacer 40. Also contained within the spacer 40, in various quadrants thereof, which will be discussed in more detail below, are the irrigation tube 44 which fluidly communicates with the irrigation port 28 and the arms of the basket assembly 18 and the aspiration tube 46 which communicates with the aspiration port 26. The aspiration tube 46 opening is positioned proximal of the balloon 80. Inflation tube 48 communicates with inflation port 30 (which receives a syringe) to inflate the balloon 80 contained within the basket assembly 18 and is also positioned within spacer 40. A valve is preferably provided to limit balloon inflation. Wires 50, only a few of which are shown in FIG. 3 for clarity, although in preferred embodiments twelve wires would be provided for the reasons described below, are also positioned within spacer 40. Wire bundle 51 is shown in FIG. 4. Fastener 52 is attached to internal threads 56 of handle 16, with spacer clamp 54 clamping fastener 52 to connect spacer 40 to handle 16 (see also FIG. 5). Note FIG. 6 illustrates the spacer 40 mounted within handle 16 with the clamp 54 removed for clarity.
In the illustrated embodiment (see FIG. 4), at least one temperature sensor is associated with each needle electrode 32. One temperature sensor 108 a senses temperature conditions near the exposed distal end of the electrode 32. A second temperature sensor 108 b is located on the corresponding spine 100, which rests against the mucosal surface when the balloon structure 80 is inflated to measure temperature of the tissue adjacent the needle electrode 32.
The irrigation tube 44 communicates with manifold 60. As shown in FIGS. 16-18, manifold 60 has an inlet opening 62 which is coupled to the irrigation tube 44 and a plurality of exit openings 64, each communicating with one of the spines 100 of the basket assembly 18. In this manner, fluid entering the manifold 60 through the single inlet opening 62 is subdivided for distribution through each of the four radially spaced spines 100 of the basket assembly 18 for exit through an irrigation opening in each of the spines 100.
With reference to FIG. 4, the basket structure will now be discussed. In the illustrated embodiment, the three-dimensional basket 18 includes one or more spines or arms 100, and typically includes four spines 100, which are held together at a distal end by a distal tip 20 and at proximal end by basket holder 84. In the illustrated embodiment, four spines 100 are shown, spaced circumferentially at 90-degree intervals.
An expandable structure comprising a balloon 80 is located within the basket arms 100. The balloon 80 can be made from various materials such as by way of example, a Polyethylene Terephthalate (PET) material, or a polyamide (non-compliant) material, or a radiation cross-linked polyethylene (semi-compliant) material, or a latex material, or a silicone material, or a C-Flex (highly compliant) material.
The balloon and basket arms are shown in FIG. 2A in a normally, generally collapsed condition, presenting a low profile for delivery into the esophagus.
A balloon tube 82 includes an interior lumen, which communicates with the interior of the balloon 80. A fitting 30 (FIG. 3), such as a syringe-activated check valve, extends from the handle 16 and communicates with the lumen in the inflation tube 48 and the lumen within the balloon tube 82. The fitting 30 couples the lumen to a syringe for injection of fluid under pressure through the lumen into the balloon structure 80, causing its expansion.
Expansion of the balloon 80 urges the basket arms 100 to open and expand to the expanded position (condition) of FIG. 2B. The force exerted by the balloon 80 and arms 100, when expanded, is sufficient to exert an opening or dilating force upon the tissue surrounding the basket arms 100. The balloon 80 can be expanded to varying diameters to accommodate for varying patient anatomy.
As noted above, the basket structure is composed of four basket arms or spines 100. Each spine 100 has three tube or spine sections 102, 104 and 106 (see e.g. FIGS. 4 and 27). The spine 100 can be formed by a tri-lumen extrusion or alternately by separate tubes attached together. Note tube 104 is positioned between tubes 102 and 106 and can have flattened surfaces 104C (FIG. 31), rather than round surfaces of tubes 102, 106, to facilitate manufacture.
Tube 102 has a proximal opening 102 a to receive the irrigation tube 44, tube 104 has a proximal opening 104 a to receive the needle electrode 32, and tube 106 has a proximal opening 106 a to receive the wires for temperature sensors 108 a, 108 b. As shown, the proximal openings 102 a, 104 a and 106 a are staggered, with the opening 102 a being the most proximal, the opening 106 a being the most distal and the opening 104 a axially intermediate openings 102 a and 106 a. Tube 102 of spine 100 has an exit opening 102 b (FIG. 28) to allow for exit of fluid into the tissue, tube 104 has an exit opening 104 b to enable the needle electrode 32 to be angularly deployed from the spine 100, and tube 106 has an opening 106 b for the sensor 108.
Balloon 80, positioned within the basket arms 102, 104, 106 has a tube 82 which is mounted within basket holder 84. Basket holder clamp 86 (FIG. 4) fixedly retains spines 100 within basket holder 84 and retains basket holder 84 within outer tube 22. Basket holder clamp 86 is seated within the outer tube 22, and outer clamp 110 is positioned over outer tube 22 and over basket holder clamp 86. Tube extension 88, extending distally from connector tube 81 attached to balloon 80, is connected within the central opening 25 of distal tip 20. The flat ends 101 of basket arms 100 connect within proximal slots 25 a of distal tip 20.
With reference to FIGS. 27-32, the basket arms (spines) 100 include a location feature or structure to maintain radial alignment/spacing. In the illustrated embodiment, the location feature includes a series of grooves on the basket arms 100 which cooperate with bumps (or projections) on the basket holder 84 so the arms 100 are maintained in radial alignment with fixed radial spacing. More specifically, a bottom surface of the tube 104 of spine 100 includes a set of four grooves 112. The grooves 110 on the top surface of arms 110 facilitate grasping during manufacture. The grooves 112 receive projections 89 on basket holder 84. That is, the configuration and dimension of the grooves correspond to the configuration and dimensions of the bumps. Thus, this location feature of the arms 100 ensures the arms are properly seated within basket holder 84 to ensure the desired alignment of the arms 100 e.g., equidistant radial spacing, is provided during manufacture and maintained during use. It should be appreciated that this location feature can alternately be configured so the projections are on the arms 100 and the grooves are in the basket holder 84. Other location/alignment engagement features are also contemplated to maintain radial alignment of the basket arms 100. Also, although four projections/grooves are provided in the illustrated embodiment, a different number can be utilized for the engagement structure. The bump/groove engagement can be a location feature which requires a clamp such as clamp ring 86 to maintain the position, or alternatively the location feature can also interlock to frictionally engage. FIG. 31 illustrates a cross-sectional view of one of the spines 100 mounted within the basket holder. Only one of the spines 100 is shown in FIG. 31 for clarity. FIG. 33 is a front view (looking distally from the proximal end) showing all four arms 100 attached thereover to the basket holder 34, with the basket holder clamp ring 86 attached to retain the holder 34 within outer tube 22.
Within basket holder 84 is lumen 114 which receives the aspiration tube 46 and lumen 116 which receives the balloon inflation tube 48.
In an alternate embodiment, U-shaped channels 176 can be provided and circular tubes (not shown) snapped into the channels. This is illustrated in FIG. 30C wherein three separate tubes (not shown) would be snapped into channels 176.
Turning now to the needle electrode assembly, the needle pusher (advancer) 42, as noted above, is connected to needle electrodes 32. Pusher 42 is coupled at its distal end to needle holder 90. Holder ring 94 (FIG. 4) is positioned over needle holder 90 and retained by clamping sleeve 92 positioned over holder ring 94. That is, clamping sleeve 92 is positioned over holder clamp 94 and needle holder 90 to fix the needle electrodes 32 within the needle holder 90.
Each spine (basket arm) 100 carries an electrode 32. Therefore, there are four electrodes circumferentially equidistantly spaced at 90-degree intervals. Each electrode 32 is carried within the tubular member or lumen 104 of spine 100 for sliding movement from a retracted position, withdrawn within the spine 100, to an extended position, extending outwardly from the spine 100 (see FIG. 2B) through opening 104 a in the lumen 104. A sliding actuator 24 (FIGS. 3 and 5) on the handle 16 as described above is coupled to the sliding electrodes 32 so that the actuator 24 controls movement of the electrodes 32 between the retracted position and the extended position (by sliding the actuator from the position of FIG. 2A to the position of FIG. 2B).
The electrodes 32 have sufficient distal sharpness and strength, when extended, to penetrate a desired depth into the smooth muscle of the lower esophageal sphincter 18 or the cardia of the stomach (see FIG. 38). The desired depth can range from about 3 mm to about 10 mm, and more preferably between about 5 mm to about 8 mm, although other depth ranges are also contemplated.
The electrodes 32 are formed of material that conducts radio frequency energy, such as by way of example nickel titanium, stainless steel, e.g., 304 stainless steel, or a combination of nickel titanium and stainless steel.
An electrical insulating material can be coated about the proximal end of each electrode so that when the distal end of the electrode penetrating the smooth muscle of the esophageal sphincter or cardia transmits radio frequency energy, the material insulates the mucosal surface of the esophagus or cardia from direct exposure to the radio frequency energy. Thermal damage to the mucosal surface is thereby avoided. The mucosal surface can also be actively cooled during application of radio frequency energy to further protect the mucosal surface from thermal damage.
The controller 9 can condition the electrodes 32 to operate in a monopolar mode. In this mode, each electrode 32 serves as a transmitter of energy, and an indifferent patch electrode (described later) serves as a common return for all electrodes 32. Alternatively, the controller 9 can condition the electrodes 32 to operate in a bipolar mode. In this mode, one of the electrodes comprises the transmitter and another electrode comprises the return for the transmitted energy. The bipolar electrode pairs can include electrodes on adjacent spines, or electrodes 32 spaced apart on different spines.
With reference to FIGS. 19-26, the needle electrodes are maintained in axial (longitudinal) and radial alignment. Each needle electrode 32 includes a location feature or structure in the form of two ribs or projections (bumps) 165, separated by grooves 166 for cooperation with grooves 97 a formed between surfaces 97 of the needle holder 90. That is, the projections 165 are configured and dimensioned to fit within grooves 97 a. Thus, during manufacture, the electrodes 32 are placed in alignment by a needle holder 90. A different number of projections and cooperating grooves is also contemplated, for the engagement structure. The bump/groove engagement can be a location feature which requires a clamp to maintain the position, or alternatively the location feature can interlock to frictionally engage. Also, alternatively, the projections could be provided on the needle holder and the grooves on the electrodes. Other engagement/location structure is also contemplated.
More specifically, FIG. 23A illustrates a needle electrode 32 just before engagement with the needle holder 90 and FIG. 23B illustrates engagement of the needle electrode with the projections/grooves of the needle holder 90. Each of the four needle electrodes 32 are interfit to the needle holder 90, separated at 90 degree intervals. Holder ring 94 is then placed over the needle holder 90 (FIG. 25) and clamping sleeve 92 (FIG. 25) is then placed over the ring 94 to provide a clamping force to hold the proximal ends of the needle electrodes 32 engaged with the needle holder 90, as shown in FIG. 26. The equidistant radial spacing and longitudinal alignment of the electrodes 32 a-32 d is illustrated in FIGS. 34A and 34B with the distal tips of the electrodes extending the same distance from the basket to terminate along the same plane. This is achieved by the aforedescribed location feature
The advantage of the alignment of the electrodes 32 can be appreciated with reference to FIGS. 35A-35C showing misalignment These Figures illustrate what can occur if the needle electrodes 32 are not properly aligned. In FIG. 35a , if the needle electrodes are not radially equidistantly spaced, then undertreatment and overtreatment areas will occur. For example, in FIG. 35a , a needle electrode 32 a is shown out of axial alignment, i.e., more than 90 degrees apart from needle electrode 32 b, and less than 90 degrees apart from needle electrode 32 d. Optimally, when RF energy is applied to the tissue via the needle electrode tips, the treatment areas are space at a minimum of 5 millimeters apart, this occurs when the electrodes are properly aligned as in the present invention. After application of RF energy, and the device is rotated 45 degrees (or 30 degrees) to provide another application of RF energy, the treatment areas will be equidistantly spaced between the two treatment areas T1 and T2 provided the electrodes are properly aligned. However, if an electrode is out of axial alignment as is electrode 32 a in FIG. 35A, space A between treatment area T3 and T4 is greater than 5 millimeters and space B between treatment areas T4 and T1 is less than 5 millimeters. Consequently, in the next application of RF energy after device rotation (FIG. 35B), treatment region T7 will be too close to treatment region T4, and can overlap region T4 which can overtreat the tissue and cause undesired tissue ablation. Conversely, treatment area T7 will be too far from treatment area T3 which will lead to undertreatment of tissue. Note new treatment region T5 is properly spaced from treatment regions T8 and T3.
The problem of misalignment and undertreatment/overtreatment is compounded since treatment is in three dimensions. That is, lesions are formed not only in an axial plane but in spaced longitudinal planes, and therefore proper spacing needs to be maintained not only in the axial lesion level, but between axial lesion levels. Therefore, when the device is moved axially to the next axial lesion level and the needle electrodes are deployed, the improper axial spacing will again cause tissue treatment areas too close or too far from other areas between axial planes.
A similar problem occurs if the needle electrodes are not longitudinally aligned i.e., the distal tips of the electrodes do not terminate the same distance from the spines 100. The locating feature of the present invention ensures that the needle electrodes distalmost end terminate at the same distal region. FIG. 35C illustrates what can occur if the needle electrodes are not longitudinally aligned in assembly and are deployed during use. As shown, improperly aligned electrode 32 f terminates more proximally than electrode 32 e since its initial position is improperly rearward of electrode 32 f. When the electrodes are deployed, electrode 32 f does not penetrate sufficiently into tissue so that when RF energy is applied, it will not treat the muscle layer but rather treat the mucosal layer. Conversely, if one of the needle electrodes is misaligned and is deployed too far, it can extend past the desired treatment area. When the device is moved to the next lesion level, the problem is compounded as the desired spacing between the treatment areas will not be maintained and RF energy in some regions will be applied too close to the previously treated area causing overheating and unwanted ablation and other regions will be applied too far from the previously treated region causing undertreatment.
As noted above, the basket arms 100 include the location feature to engage the feature on the basket holder 84. If the basket arms are not properly radially spaced e.g., not spaced equidistantly, then when the needle electrodes 32 are advanced through the apertures in the arms 100, they will not be equidistantly spaced, resulting in the undertreatment/overtreatment of tissue discussed above. That is, if one of the arms 100 for example is improperly skewed so it is spaced more than 90 degrees from an adjacent arm, and closer than 90 degrees from the other adjacent arm, when the needle electrodes 32 are advanced from these arms, the tips would likewise be skewed and not spaced 90 degrees apart, resulting in the aforementioned problems of not maintaining the desired spacing.
An alternate embodiment of the electrode tip is shown in FIG. 41. In this embodiment, rather than a penetrating tip, the electrodes 162 have a substantially conical tip 162 a, tapering in a distal direction. The substantially conical tip 162 a is non-penetrating and when advanced toward tissue and into contact with the tissue, upon sufficient force, deforms the tissue. As shown, the tissue is compressed and forms around the substantially conical tip 162 a as the tip is indented into tissue. Energy applied to the conical tip 162 a heats the tissue for treatment as described herein.
Turning now to more details of the spacer 40, spacer 40 has a proximal end 40 a connected to fastener 52 (FIG. 3) as discussed above. The distal end 40 b (FIG. 4) connects to fastener 55, and can be flared as shown, and is retained within outer tube 22 by distal clamp 70. With reference to FIGS. 8A and 9-15, spacer 40 has a central circular rib 142 dimensioned to slidingly receive needle pusher 42. Emanating from the circular rib 142 are four transverse ribs 120, 122, 124 and 126 which subdivide the spacer 40 into four longitudinally extending quadrants 130, 132, 134, and 136. Thus, quadrant 130 is formed between ribs 120, 122, quadrant 132 is formed between ribs 122 and 124, quadrant 134 is formed between ribs 124 and 126 and quadrant 136 is formed between ribs 126 and 120. A pair of wires 50 are received in each of the quadrants, best shown in FIGS. 8 and 9, forming thermocouples for measuring tissue temperature of the tissue adjacent the needle electrodes 32. The spacer 40 is preferably in the form of a plastic tube formed by an extrusion. The spacer also functions to maintain centering of the needle advancer during flexing of the catheter. That is, the slider/actuator 24 movement correlates one to one with movement of the needle advancer 42 and thus the needle electrodes 32. If not retained in the channel in the center then the needle electrodes 32 would be at a greater distance if the catheter tube 22 was bent in one direction and be at a shorter distance if the catheter 22 was bent in a different direction. This shorter distance can result in insufficient penetration resulting in undertreatment while on the other hand, movement a longer distance can result in over penetration. That is, this varied depth penetration can cause undertreatment or overtreatment which can lead to ablation of the tissue, as described in detail herein in conjunction with non-alignment of the electrodes and/or basket arms.
The outer wall 138 of spacer 140 is formed with slits to access each quadrant or area 130, 132, 136, and 138. More specifically, slit 140 a enables access to area 130, slit 140 b enable access to area 142, slit 140 c enables access to area 134 and slit 140 c enables access to area 136. The slit is separable during manufacture so the wires 50, irrigation tube 44 and aspiration tube 46 can be placed in the areas during manufacture. This facilitates manufacture, as the flap formed by the slit can be progressively opened and the wires and tube placed inside the area 130-136, with the flap self closing to retain the components within the spacer.
The spacer can in some embodiments be formed of a material more rigid than the outer tube. This enables a more flexible outer tube to be utilized as the spacer rather than the outer tube is utilized to provide a sufficiently rigid structure to retain the needle advancer.
Placement of all the wires and tubes are illustrated in FIG. 8A, with the thermocouple wires 50 placed in each of the quadrants 132-138. Irrigation tube 44 is within quadrant 134, balloon inflation tube 48 is within quadrant 138 and aspiration tube 46 is within quadrant 136.
In the alternate embodiment of FIG. 8B, instead of four separate quadrants, a rib 152 transitions into circular rib 154 to retain the needle pusher 42 in a centered position within the spacer. Instead of four separate quadrants, some wires 50, aspiration tube 44, and balloon inflation tube 48 are placed in one quadrant and irrigation tube 44 and other wires 50 are placed in a second quadrant of the spacer 140. A slit 156 a and 156 b, similar to slits 140 a and 140 b of FIG. 8A, are provided to form a flap to enable access to the interior of the spacer in the same manner as described above. It should also be appreciated that a different number of ribs 152 can be provided to provide a different number of quadrants. For example, three ribs 152 can be provided to create three quadrants.
As noted above, the external fluid delivery apparatus 6 is coupled via tubing 6 a (see FIG. 1) to connector 28 (see FIG. 4), to supply cooling liquid to the targeted tissue, e.g., through holes in the spines. The external aspirating apparatus 8 is coupled via tubing 8 a (see FIG. 1) to connector or aspiration port 26 (see FIG. 3) to convey liquid from the targeted tissue site, e.g., through one of the tubes or lumens in the spines 100. The controller 9 can govern the delivery of processing fluid and, if desired, the removal of aspirated material.
FIGS. 40-46B illustrate various embodiments of a mechanism for disabling suction (aspiration) through the aspiration (suction) tube of the device. Note the terms suction and aspiration are used herein interchangeably. In several of the embodiments, a disabler is movable between two positions: in one position a side opening in the aspiration tube is covered to enable suction through the aspiration tube; in another position the side opening is open to disable aspiration through the aspiration tube. In several other embodiments, the disabler is movable to pinch the aspiration tube to close off the lumen in the tube. By disabling aspiration during the surgical procedure, movement of the device within the patient's body is facilitated since it avoids tissue being caught in the instrument during such movement. In other words, when it is desired to move the instrument to the next axially spaced lesion level as described herein, the vacuum can be disabled at the handle section of the device without having to shut off the vacuum, thereby facilitating movement. By placement at the handpiece, the user does not have to keep turning the vacuum on and off, but rather can control aspiration at the handle when desired. Location of the control for the disabler is shown in FIG. 40 by way of example.
The suction disabler also helps obtain treatment without ablating tissue by ensuring the tissue (and not just the device) is properly positioned for application of energy. For example, if tissue is retained against the device due to the suction, e.g., around the basket or balloon, and the device is moved axially, the tissue can be pulled from its “normal” position along with the device. If this occurs, when the electrodes are redeployed and energy is applied, the energy could undesirably be applied to the same region of tissue as previously applied rather than a new region of tissue which can cause overtreatment of tissue and ablation. Also, by not treating the new region under treatment can occur. In other words, the undesired movement of tissue can adversely result in improper spacing of tissue regions receiving energy, causing the undesired consequences described herein. Therefore, the suction disabler, by cutting off suction, releases any tissue “hugging” the device to avoid unwanted movement of tissue during axial movement of the device to treat the next level of tissue.
Turning first to the embodiments which disable aspiration (suction) by controlling the covering of a side opening in the aspiration tube, a first embodiment of a aspiration (suction) disabler, designated generally by reference numeral 210, is shown in FIGS. 40-41D. The aspiration (suction) tube 200 has an opening 202 in its side wall. Suction is applied via external aspiration source such as aspiration source 8 of FIG. 1A which is coupled to aspiration port 26 in the device handle. Suction disabler 210 is slidable from a first position of FIG. 41A wherein the opening 202 in aspiration tube 200 is closed off to enable suction through tube 200 to a second position wherein the opening 202 is open so that suction is disabled. More specifically, suction disabler 210 includes a slidable control or lever 212, a post 214 extending inwardly from the lever 212 (toward the tube 200) and a cover 216 at the opposing end of the post 214. A gripping surface 213 can be provided on an external surface of lever 212 for ease of sliding. Lever 212 extends through a slot 223 in the handle housing 228. Preferably, the disabler 210 is formed of a monolithic or unitary piece, although it is also contemplated that one or more of the lever, post or cover can be a separate component and attached together.
A support block 218 is attached to the aspiration tube 200 such as by gluing or other methods. A cylindrical portion 220 extending from the inner surface of support block 218 extends into opening 202 of aspiration tube 200 and the outer wall portion 203 of the aspiration tube 200 is seated on shoulder 222 as shown in FIGS. 41A and 41B. The support block 218 includes a slot 225 dimensioned to receive post 214 to enable sliding movement of the post 214 and slot portion 226 receives cover 216. The cover 216 is movable between two positions: to cover and thereby close off the opening 202 in the sidewall 203 of the aspiration tube 200 to enable aspiration or uncover the opening 202 to disable aspiration.
In use, when suction is desired, the lever 212 is moved by the user to the positon of FIG. 41A. In this position, the cover 216 covers the outer opening in the cylindrical portion 220 to seal the opening. Thus, blood or other particles can be suctioned through the tube 200 in the direction of the arrows of FIG. 41A, exiting a proximal end of the tube. When it is desired to disable suction, the lever 212 is moved to the position of FIG. 41B wherein the opening 202 in the side wall 203 of tube 200 is uncovered as cover 216 provides a gap so that a vacuum is not created through tube 200. Note that the post 214 slides within the slot 225 in the support block 218 to enable back and forth movement of the cover 216. In this manner, the user can selectively enable and disable suction as desired. Note the lever's normal (or original) position can be either that of FIG. 41A or FIG. 41B, and a locking mechanism can be provided to retain the lever in either or both the positions of FIGS. 41A and 41B. A spring could be provided to bias the lever to one of the positions.
In the alternate embodiment of FIGS. 42A and 42B, suction disabler 230 includes a slidable control or lever 232, a two bar linkage having outer bar 234 and inner bar 236. Outer bar 234 is pivotably attached to support post 238 via pivot pin 240 and pivotably attached to inner bar 236 via pivot pin 242. A support block 235 is attached to an outer surface of the aspiration tube 200 such as by gluing or other known methods, with stem 237 extending into the opening 202. A shoulder 239 of support block 235 supports the wall of the aspiration tube 200. Inner bar 236 is L-shaped as shown so that horizontal cover portion 244 is substantially parallel to a longitudinal axis of the aspiration tube 200 in the first position of the disabler 230. Cover portion 244 in this first position, covers the opening 202 in the aspiration tube 200 which allows aspiration through tube 200. In the second position, cover portion 244 is pivoted towards and into the lumen 203, thereby uncovering and opening side opening 202 in the aspiration tube 200 for escape through the side opening 202 of tube 200 and support block 235 so a vacuum is not created. This is achieved by sliding the lever 238 distally from the position of FIG. 42A to the position of FIG. 42B to cause pivoting of the linkage as shown.
In use, when suction is desired, the lever 232 is moved by the user to the positon of FIG. 42A. In this position, the cover 244 covers the opening 202. Thus, blood or other particles can be suctioned through the tube 200 in the direction of the arrows of FIG. 42A. When it is desired to disable suction, the lever 232 is moved to the position of FIG. 42B wherein the opening 202 in the side wall is uncovered as cover 244 is pivoted into the lumen of the aspiration tube 200 so that a vacuum is not created. In this manner, the user can selectively enable and disable suction as desired. Note the lever's normal (or original) position can be either that of FIG. 42A or FIG. 42B, and a locking mechanism can be provided to retain the lever in either or both the positions of FIGS. 42A and 42B. A spring could be provided to bias the lever to one of the positions.
In the embodiment of FIGS. 43A and 43B, suction disabler 250 includes a spring biased elongated cover 252 movable transverse to a longitudinal axis of the aspiration tube 200. Cover 252 with elongated stem 253 is shown biased by spring 254 to an outer position, i.e., further from the longitudinal axis of the aspiration tube 200. Stem 253 moves within support housing 256, which also contains the spring 254 therein. Support housing 256 is attached to the aspiration tube 200 by gluing or by other known methods. Spring 254 rests on ledge 258 of stem 253 and is compressed as shown in FIG. 43B when the cover 252 is moved from its outer to its inner position. Housing 256 includes inner portion 260 which extends into the opening 202 in the aspiration tube 200, and an outer wall of the aspiration tube 200 rests on shoulder 264 of housing 256. When cover 252 is in the outer position of FIG. 43A, aspiration opening 202 is closed and suction can occur through the aspiration tube 200 in the direction of the arrows of FIG. 43A. When the cover 252 is moved inwardly toward the lumen 201 of the aspiration tube 200 as stem 253, which extends through the an opening in handle housing 251, is moved toward the tube 200, a gap is created between cover 252 and opening 202 so a vacuum is not created.
In use, when suction is desired, the cover 252 is maintained in the positon of FIG. 43A. In this position, the cover 252 covers the opening 202 in the aspiration tube 200 to seal the opening. Thus, blood or other particles can be suctioned through the tube 200 in the direction of the arrows of FIG. 43A. When it is desired to disable suction, the exposed end 253 of cover 252 is pressed inwardly toward the tube 200 by the user to the position of FIG. 43B wherein the opening 202 in the side wall is uncovered as cover 252 enables formation of a gap so that a vacuum is not created. In this manner, the user can selectively enable and disable suction as desired. Note that as the cover 252 is pressed inwardly, the spring 254 is compressed. Therefore, once the user releases cover 252, it returns to the position of FIG. 43A under the force of spring 254. Note the cover's normal (or original) position can be either that of FIG. 43A or FIG. 43B, and a locking mechanism can be provided to retain the cover in either or both the positions of FIGS. 43A and 43B.
In the embodiments of FIGS. 41-43, the suction disabling is achieved by uncovering a side opening 202 in the wall of the aspiration tube 200. Several examples of mechanisms to close or cover the side opening are disclosed by way of example, it being understood that alternative mechanisms to cover and uncover the opening can be provided to obtain such disabling. In the alternate embodiments of FIGS. 44A-46B, aspiration disabling is achieved by deforming the wall of the aspiration tube to block flow. Some examples of this structure for disabling suction are discussed below, it being understood that alternative mechanisms can be provided to close off the tube to obtain such disabling. It both versions, preferably the control to disable suction is positioned on the handle housing to facilitate access and manipulation by the user.
Turning first to the embodiment of FIGS. 44A and 44B, suction disabler 260 includes a pivotal lever 262, substantially L-shaped in configuration, and attached to housing 270 by pivot pin 272. One leg 264 of the lever extends transverse to a longitudinal axis of the aspiration tube 300 and has an irregular surface 266 to facilitate manipulation by the user. Leg 264 extends through opening 261 in the handle housing 263, and the irregular surface 266 is exposed for manipulation by the user. The other leg 268 of lever 262 is substantially perpendicular to leg 264 and extends substantially along the longitudinal axis of the aspiration tube 300. The initial position of suction disabler 260 is shown in FIG. 44B.
Leg 268 terminates in bent tip 267 with tube contacting surface 269. Tip 267 is shown at an angle of about 90 degrees but other angles are also contemplated. Tip 267 applies a force to tube 300 to pinch tube 300 and close lumen 301 extending through tube 300.
In use, to allow suction, pivotal lever 262 is in the position of FIG. 44A with suction enabled in the direction of the arrows. To disable suction, pivotal lever 262 is pivoted about pivot pin 272 to the position of FIG. 44B, therefore moving tip 267 toward tube 300 and applying a radial force to the tube 300 to move the wall into apposition to seal off the vacuum. Note a locking mechanism can be provided to retain the pivotal lever 262 in the suction enabling position of FIG. 44A and/or the suction disabling position of FIG. 44B. A spring can be provided to bias the lever 262 to either the position of FIG. 44A or 44 b.
The pinching/clamping of the aspiration tube 300 can also be achieved by sliding movement instead of pivoting member as in FIG. 44A. In FIG. 45A, suction disabler 280 includes a spring biased pinching member or button 282 movable transverse to a longitudinal axis of the aspiration tube 300. Member 282 is shown biased by spring 284 to an outer position, i.e., further from the longitudinal axis of the aspiration tube 300. Member 282 slidably moves within support housing 286, which also contains the spring 284 therein. Support housing 286 is positioned circumferentially about the aspiration tube 300 and can be attached by gluing or by other known methods. Spring 284 rests on ledge 288 of member 282 and is compressed as shown in FIG. 45B when the pinching member 282 is moved from its outer to its inner position. When member 282 is in the outer position of FIG. 45A, aspiration lumen 301 of aspiration tube 302 is open and suction can occur through the aspiration tube 300 in the direction of the arrows of FIG. 45A. When the pinching member 282 is moved inwardly toward the aspiration tube 301, it pinches the wall of the tube so that it closes off lumen 301 to disable suction through lumen 301.
In use, when suction is desired, the pinching member is maintained in the positon of FIG. 45A. In this position, the pinching member 282 does not deform the wall of the aspiration tube 300 so that vacuum can be applied and blood or other particles can be suctioned through the tube 300 in the direction of the arrows of FIG. 45A. When it is desired to disable suction, the exposed end 283 of pinching member 282 (extending through an opening 287 in housing 281) is pressed inwardly by the user to the position of FIG. 45B wherein the wall of the aspiration tube 300 is pinched or deformed to close off flow through the lumen 301. In this manner, the user can selectively enable and disable suction as desired. Note that as the member 282 is pressed inwardly, the spring 284 is compressed. Therefore, once the user releases member 284, it returns to the position of FIG. 45A under the force of spring 284. Note the pinching member's normal (or original) position can be either that of FIG. 45A or FIG. 45B, and a locking mechanism can be provided to retain the pinching member in either or both the positions of FIGS. 45A and 45B.
The suction disabler 280 can be provided with an interlock to maintain the pinching member in the clamping position. An example of such interlock is shown in FIGS. 46A-46B. The suction disabler of FIGS. 46A and 46B is identical to the suction disabler of FIGS. 45A and 45B except for the interlock. Therefore, for brevity, a discussion of each of the same features are not repeated herein and the same features/components are labeled with “prime” designations corresponding to the labeling of FIGS. 45A and 45B. Thus, suction disabler 280′ has a spring biased pinching member or button 282′ extending through housing 281′ and movable transverse to a longitudinal axis of the aspiration tube 300. Member 282′ is shown biased by spring 284′ to an outer position, i.e., further from the longitudinal axis of the aspiration tube 300. Member 282′ slidably moves within support housing 286′, which also contains the spring 284′ therein. Support housing 286′ is positioned circumferentially about the aspiration tube 300 and can be attached by gluing or by other known methods. Spring 284′ rests on ledge 288 of member 282′ and is compressed as shown in FIG. 46B when the pinching member 282′ is moved from its outer to its inner position.
The interlock includes a retention feature 290 in the form of a screw thread engagement. When the pinching member 282′ reaches its furthest inward travel, it is rotated so that its threaded inner surface 291 engages the outer threads 289 on support housing 286′. To unlock, the pinching member 282′ is rotated in the reverse direction to release the retention feature 290.
Turning now to the use of the device for applying energy to form lesions and with reference to device 10, the device 10 is manipulated to create a preferred pattern of multiple lesions comprising circumferential rings of lesions at several axially spaced-apart levels (about 5 mm apart), each level comprising from 8 to 12 lesions. A representative embodiment of the lesion pattern is shown in FIG. 39. The rings are preferably formed in the esophagus in regions above the stomach, at or near the lower esophageal sphincter, and/or in the cardia of the stomach. The rings in the cardia are concentrically spaced about the opening funnel of the cardia. At or near the lower esophageal sphincter, the rings are axially spaced along the esophagus. As shown, the device is inserted in the collapsed position of FIG. 36, expanded to the position of FIG. 37 by inflation of the balloon to dilate the sphincter and then the needle electrodes 32 are advanced into tissue as shown in FIG. 38 for application of energy.
Multiple lesion patterns can be created by successive extension and retraction of the electrodes 32, accompanied by rotation and/or axial movement of the catheter tube to reposition the basket assembly 18. The physician can create a given ring pattern by expanding the balloon structure 80 and extending the electrodes 32 at the targeted treatment site, to form a first set of four lesions. The physician can then withdraw the electrodes 32, collapse the balloon structure 80, and rotate the catheter tube 22 by a desired amount, e.g., 30-degrees or 45-degrees, depending upon the number of total lesions desired within 360-degrees. The physician can then again expand the structure 18 and again extend the electrodes 32, to achieve a second set of four lesions. The physician repeats this sequence until a desired number of lesions within the 360-degree extent of the ring is formed. Additional lesions can be created at different levels by advancing the operative element axially, gauging the ring separation by external markings on the catheter tube.
As shown in FIG. 39, a desirable pattern comprises an axially spaced pattern of six circumferential lesions numbered Level 1 to Level 6 in an inferior direction, with some layers in the cardia of the stomach, and others in the esophagus above the stomach at or near the lower esophageal sphincter. In the embodiment shown in instant FIG. 5, in the Levels 1, 2, 3, and 4, there are eight lesions circumferentially spaced 45-degrees apart (i.e., a first application of energy, followed by a 45-degree rotation of the basket 56, followed by a second application of energy). In the Levels 5 and 6, there are twelve lesions circumferentially spaced 30-degrees apart (i.e., a first application of energy, followed by a 30-degree rotation of the basket 56, followed by a second application of energy, followed by a 30-degree rotation of the basket assembly 18, followed by a third application of energy). In Level 5, the balloon 80 is only partially expanded, whereas in Level 6, the balloon 80 is more fully expanded, to provide lesion patterns that increase in circumference according to the funnel-shaped space available in the funnel of the cardia.
Note that to secure against overinflation of the balloon, especially in tissue Levels 1-4 where the device is positioned in the esophagus, a pressure relief valve is attached to the air syringe, upstream of the balloon inflation port of the device, to allow air to escape if pressure levels are exceeded. That is, in Levels 1-4, the air syringe is filled with air, and the balloon is inflated to a target pressure so there is enough contact to slightly tension the tissue but not enough to stretch the tissue, with the pressure relief ensuring the pressure is not exceeded. Preferably, the balloon would be inflated to no more than about 2.5 psi. In the stomach, at Levels 5 and 6, there is more room for the balloon inflation, so the balloon can be further inflated and the pressure relief valve can be removed. The balloon is preferably inflated by volume to about 25 ml for treatment at Level 5, and after treatment at Level 5, deflated at Level 6 to about 22 ml. Note at Levels 5 and/or 6, the inflated balloon can also be used as an anchor. In an alternate embodiment, after treatment of Level 4 the balloon is deflated and the instrument is advanced, then retracted, wherein Level 6 is treated, then the instrument is pulled further proximally to subsequently treat Level 5. Stated another way, Level 5 can be considered distal of Level 6 and therefore being more distal, treated before Level 6. Note the balloon would still be inflated to about 25 ml in the more distal level and to about 22 ml in this embodiment. The balloon can also serve as an anchor.
In an alternate embodiment of the device 10, one or more digital cameras can be mounted along the catheter tube, e.g., with the camera lens directed to the basket assembly 18, to provide visualization of the site. In another alternate embodiment, the catheter tube can be designed to fit within a lumen of an endoscope, relying on the endoscope for visualization of the site.
A. Set-Up
In use, the GUI displays an appropriate start-up logo and title image (not shown), while the controller 52 performs a self-test. An array of SETUP prompts 502 leads the operator in a step-wise fashion through the tasks required to enable use of the generator and device. The GUI is described in detail in Publication No. 2011/0112529, the entire contents of which are incorporated herein by reference and therefore for brevity is not repeated herein.
The physician can couple the source of cooling liquid to the appropriate port on the handle of the device 10 and load the tubing leading from the source of cooling liquid (e.g., a bag containing sterile water) into the pump. The physician can also couple the aspiration source 8 to the appropriate port on the handle of the treatment device 10. In the SET-UP prompt array, a graphic field of the GUI displays one or more icons and/or alpha-numeric indicia that prompt the operator to connect the return patch electrode, connect the foot pedal or switch 41, connect the selected treatment device 10 (designed by its trademark STRETTA®) and to prime the irrigation pump.
Note in some embodiments, the user controls the pump speed to increase fluid flow if the temperature is rising. In alternate embodiments, the system is designed with an automatic cooling feature, thus enabling quicker application of cooling fluid to address rising tissue temperatures to faster cool the tissue surface which in turn cools the underlying tissue which helps to maintain the tissue temperature below the “tissue ablation threshold.”
More specifically, at certain tissue temperatures, the speed of the pump is changed automatically to reduce the temperature. That is, if the tissue surface temperature, e.g., at the mucosa layer as measured by the tissue temperature sensor, reaches a certain threshold (a “first value”), the pump speed will increase to pump more cooling fluid to the tissue. In some embodiments, for certain tissue temperature values, the system can enable the user to override the automatic pump to reduce the fluid flow. In other embodiments, a user override feature is not provided. In either case, the system is preferably designed so that if a second predetermined higher temperature value (“second value”) is reached, the pump is automatically moved to its maximum pump speed, which preferably cannot be overridden by the user. When a third predetermined still higher tissue temperature value is reached (a “third cutoff value”), the electrode channel is disabled as discussed herein to shut off energy flow to that electrode. Consequently, before the third cut off value is reached, as the temperature is rising, the system provides for a quicker response to the rising temperature by automatically increasing fluid flow, rather than relying on the slower response time of the user to implement the pump speed change, thereby helping to keep temperature below the tissue ablation threshold temperature.
Exemplary tissue values are provided solely by way of example, it being understood that other tissue values can also be utilized to achieve quick application of cooling fluid and ensure the non-ablation, and non-burning, of tissue. For example, in the upper GI tract treatment device described herein (see FIG. 3), the first value could be about 38 degrees, the second predetermined value could be about 40 degrees and the third value where the energy is shut down could be about 43 degrees. For a lower GI tract treatment device described herein (see FIG. 6), the first value could be about 45 degrees, the second predetermined value could be about 46 degrees and the third value where the energy is shut down could be about 54 degrees.
If the identification code for the device is registered, the GUI displays an appropriate start-up logo and title image for the device.
In some embodiments, the coded identification device is part of a printed circuit board (PCB) positioned in the handle of the treatment device. The PCB processes the calculated parameters. The PCB in conjunction with thermocouples provides a temperature measurement mechanism. The PCB measures the voltage generated by the thermocouples, converts it from an analog to a digital value and stores it in the internal memory. Upon request by the generator, the PCB communicates the digital data to the generator. This step is performed during the 100 millisecond break between radiofrequency pulses discussed below. By placement of the temperature measurement mechanism in the treatment device, i.e., in the disposable handpiece, rather than in the housing 400, data collection is closer to the source which translates into less noise susceptibility and improved accuracy. That is, since processing of temperature values occurs closer to the tissue and electrode tip, measurements can be more accurate. More accurate readings translate into tighter power controls and better clinical results and it better ensures the tissue is not ablated during treatment as it is maintained below a tissue ablation threshold.
In a preferred embodiment, the PCB, which is asymmetrically positioned within the handle, is shielded to reduce interference which could otherwise disrupt communication between the disposable treatment device and the generator. Such interference (noise) could corrupt the data and unnecessarily result in system errors which can unnecessarily shut down energy flow to the electrode(s) during the procedure. In a preferred embodiment, the shield is a copper foil, although other ways to shield the PCB are also contemplated. In other words, the disruption of communication could adversely affect processing and evaluation of the data collected by the treatment device. By eliminating such disruptions, and thereby disabling fewer electrodes, improved consistency of treatment is achieved. Also, as can be appreciated, if too many electrodes are disabled in a procedure, the tissue may not be sufficiently thermally treated to achieve the desired clinical result.
In an alternate embodiment, the identification code is positioned in the handle of the treatment device 10, but the other hardware, e.g., the printed circuit board for temperature calculation, etc. is outside the handle. Thus, the temperature data collection is performed outside the disposable treatment device which reduces costs since it need not be disposed of with the disposable treatment device. Note these embodiments still have the advantage of data collection closer to the source than if in the housing 400.
Upon completion of the SET-UP operation, the controller 52 proceeds to condition the generator and ancillary equipment to proceed step-wise through a sequence of operational modes. The operational modes have been preprogrammed to achieve the treatment protocol and objective of the selected device 10.
In the GUI, there is a parameter icon designating cooling fluid flow rate/priming. The Flow Rate/Priming Icon shows the selected pump speed by the number of bars, one bar highlighting a low speed, two bars highlighting a medium speed, and three bars highlighting a high speed.
Each GUI includes an Electrode Icon comprising an idealized graphical image, which spatially models the particular multiple electrode geometry of the device that has been coupled to the controller 42. This is illustrated and described in detail in Patent Publication No. 2011/0112529.
In some embodiments, temperature of the needle tips is measured when the needles are deployed at the lesion level, but prior to application of RF energy. If the measured temperature exceeds an expected value, the temperature reading alerts the user that the needle position might need to be readjusted. If the temperature value is too high, this can mean that the electrode position is too close to the previous tissue level treated, and thereby the user can readjust the electrode position by increasing the spacing, thereby reducing the chances of overtreating the tissue which can cause undesired tissue ablation or burning of tissue. Consequently, continuous treatment of tissue can be achieved with reduced overlapping of treatment.
Also, as can be appreciated, the temperature of the electrode tip, the tissue temperature and the impedance, along with other safety parameters, such as adequate connections, are monitored during the procedure to ensure energy flow is correct. This includes proper flow through the cable, electrodes, ground pad, etc. The electrode needle is then disabled if a safety condition is suspected and indicated. Each needle can be controlled separately.
In use of the system, impedance is intermittently checked throughout the procedure. Impedance is measured by measuring the current at the channel of the electrode tip. The impedance monitoring provides an indication of how well the treatment device is connected and communicating with the tissue, which includes the needle penetration and the path with the return pad. If there is not good contact between the electrode and tissue, impedance is high and a patient can get burned. Therefore, if a patient moves, needle penetration could be affected. However, oftentimes a minor adjustment can be made which does not require shutting down energy flow. To avoid premature shutting down of the system a multiple error check is conducted by the system which is described in more detail below. This multiple error check reduces the incidence of needle disabling which in turn reduces the incidence of undertreatment.
Note the impedance is measured by applying a voltage, measuring the current and calculating the impedance. The RF energy is applied in 0.9 second intervals, with a 0.1 second break in between where an artificial pulse is sent for 0.1 second, in which impedance is measured. The temperature of the electrode tip and tissue temperature is also measured during this 0.1 second interval, for calculating such measurement. Preferably, the RF energy is repeatedly applied for 0.9 seconds, with 0.1 second “measurement intervals” for a time period of 60 seconds.
There is also a Lesion Level Icon in each display adjacent to the respective Electrode Icon. The Lesion Level Icon comprises an idealized graphical image, which spatially models the desired lesion levels and the number of lesions in each level, described in detail in Patent Publication 2011/0112529. As described in this publication, the Lesion Level Icons change in real time, to step-wise guide the physician through the procedure and to record the progress of the procedure from start to finish.
The GUI graphically changes the display of the Lesion Levels, depending upon the status of lesion formation within the respective levels.
The open segments remaining in the segmented circle prompt the physician to rotate the basket by 45-degrees, and actuate the electrodes for second time. After the pre-set period (tracked by the Timer Icon), more treatment indicia (the dots) appear in the remaining segments of the circle. This indicates that all the lesions prescribed for Lesion Level 1 have been formed, and to deflate the basket and move to the next treatment level. The Marker that is displayed directs the physician to Lesion Level 2, which is 5 mm below Lesion Level 1. The Balloon Icon can reappear to prompt the physician to deflate the balloon.
The physician is thereby prompted to deflate the basket, move to Lesion Level 2, and expand the basket. Upon sensing electrode impedance, indicating contact with tissue at Lesion Level 2, the GUI changes the graphical form of Lesion Level 1 back to an edgewise cylinder. The edgewise cylinder for Lesion Level 1 includes an indicator, e.g., checkmark, to indicate that Lesion Level 1 has been treated. The insertion of the treatment completed indicator is yet another graphical form the GUI displays to communicate status information to the physician.
With the device positioned at Lesion Level 2, the physician actuates the electrodes for a first pre-set period, then rotates the device 26 a 45-degrees, and actuates the electrodes for the second pre-set period. The Timer Icon reflects the application of radio frequency energy for the pre-set periods, and the treatment indicia (e.g., dots) are added to the segments of the graphical segmented circle, indicating the formation of the first four lesions and the next four lesions, as well as their spatial orientation.
The physician is thereby prompted to deflate the basket, move to Lesion Level 3, and expand the basket upon sensing electrode impedance, indicating contact with tissue at Lesion Level 3.
The physician proceeds to form eight lesions in Lesion Level 3 then moving on to Lesion Level 4. All the while, the GUI visually records and confirms progress. On Lesion Levels 5 and 6, twelve lesions are to be formed. In the Levels 5 and 6, there are twelve lesions circumferentially spaced 30-degrees apart (i.e., a first application of energy, followed by a 30-degree rotation of the basket 56, followed by a second application of energy, followed by a 30-degree rotation of the basket 56, followed by a third application of energy). In Level 5, the balloon structure is only partially expanded, whereas in Level 6, the balloon structure 72 is more fully expanded, to provide lesion patterns that increase in circumference according to the funnel-shaped space available in the funnel of the cardia.
Thus, the GUI, by purposeful manipulation of different stylized graphical images, visually prompts the physician step wise to perform a process of forming a pattern of lesions comprising a plurality of axially spaced lesion levels, each lesion level comprising a plurality of circumferential spaced lesions. The GUI registers the formation of lesions as they are generated in real time, both within and between each circumferentially spaced level. The GUI therefore displays for the physician a visual record of the progress of the process from start to finish. The GUI assures that individual lesions desired within a given level are not skipped, or that a given level of lesions is not skipped.
In the GUI, each Lesion Level 1 to 6 is initially depicted by a first stylized graphical image comprising an edgewise cylinder with a number identification of its level. When the formation of lesions at a given level is indicated, the GUI changes the first stylized graphical image into a second stylized graphical image, different than the first image, comprising an axial view of the cylinder, presented as a segmented circle, with the numbers of segments corresponding to the number of lesions to be formed. There also appears juxtaposed with the next lesion level to be treated (still displayed as an edgewise cylinder), a marker along with a number indicating its distance from the present legion level. As the physician manipulates the device to form lesions on the indicated levels, the second graphical image further changes to a third graphical image, different than the first or second images, by adding indicia within the segmented circle to reflect the formation of lesions, to guide the physician to successively rotate and operate the device at the lesion level. Upon forming the desired lesion pattern on a given level, the UGUI 504 again changes the third graphical image to a fourth graphical image, different than the first, second, and third graphical images, comprising an edgewise cylinder with a number identification of its level, and further an indicator (e.g. a check mark) that indicates all desired lesions have been formed at the respective level. A Marker is successively updated to direct the physician to the next Lesion Level. In this way, the GUI prompts the formation of eight lesions circumferentially spaced 45-degrees apart in the Levels 1, 2, 3, and 4, and the formation of twelve lesions circumferentially spaced 30-degrees apart at Lesion Levels 5 and 6. Thus, a total of 56 lesions can be formed in this procedure.
During the procedure utilizing the radiofrequency treatment device 10, certain error messages are graphically indicated on the GUI. Certain of these error messages relate to user errors which could be in the user's control, and therefore could potentially be correctable by the user. For example, if there is an error in the treatment device connection, the generator returns to the set up screen and the icon representing the treatment device displayed by the GUI begins flashing. Another example is if the error relates to the return pad, e.g., improper placement or contact of the pad, the generator likewise returns to the set up screen and the return pad icon displayed by the GUI begins flashing. Another example is if the needles are not treated properly. With these errors indicated, the user can attempt to make the proper adjustments, e.g., check the connection of the treatment device, adjust the position of the return pad, etc. By easily identifying these correctible errors, the system will shut down fewer times thereby enabling the creation of more lesions. Stated another way, the instrument continuously measures temperature which is transmitted back to the generator. The generator expects the temperature to be in a certain range. If the temperature does not appear right, e.g., is outside an expected range, if the RF channel was immediately shut down, then it could result in premature/unnecessary termination of RF energy which could undertreat tissue. Therefore, the present invention provides steps to ensure a shut down result is truly necessary, thus advantageously limiting undertreatment of the tissue. Similarly, if calculated impedance from current measurement does not appear correct, i.e., is outside a desired range, e.g. 50-500 ohms for the instrument of FIGS. 6 and 50-100 ohms for the instrument of FIG. 2, the system of the present invention ensures that a channel shut down is warranted before shut down, again avoiding premature/unnecessary termination of RF energy which can result in undertreatment of tissue.
The system, due to its faster processing speed which enables faster processing of data and faster adjustment of parameters, enables rechecking of detected errors to reduce the instances of prematurely shutting down energy flow to an electrode. As discussed above, premature termination of energy flow can result in insufficient application of thermal energy which in turn can result in undertreatment of tissue. In other words, the system advantageously is designed to reduce the number of events that would lead to energy cutoff to an electrode. More specifically, during the treatment cycles, oftentimes an error is detected which can be readily addressed by the user, such as by a small adjustment of the treatment device position if the error is caused for example by patient movement which affects the impedance reading, or even self-adjusts. If the system was designed to immediately shut down upon such error detection, then the electrode would be disabled and the lesion might not be created in that tissue region. Therefore, to reduce these occurrences, the system has been designed to recheck certain errors.
More specifically, for certain detected errors, the system does not permanently interrupt energy flow on the first error reading, but suspends energy flow until a second check of the system is performed. If on the second check the error is no longer detected, energy flow is resumed. However, if on the second check, e.g., re-measurement/calculation, an error still exists, the system runs yet a third check. If the error no longer exists, the energy flow resumes; if the error still exists, energy flow is cut off to that electrode at that treatment position. Consequently, only after the system runs a triple check is a final determination made to either transition back to energy flow or record the error and disable the electrode channel, i.e., shut down RF energy flow to that electrode. Thus, the error can be checked multiple times to ensure it actually requires interruption of energy flow, thus avoiding premature disabling of an electrode to thereby enhance tissue treatment by not skipping tissue levels, or regions (quadrants) within each tissue level which could otherwise have been treated. As a result, a more comprehensive and uniform tissue treatment is achieved.
This triple error checking feature exemplifies the speed of the processor which enables quicker processing of temperature calculations and quicker response to address rising temperatures so the tissue is not treated above the tissue ablation threshold. As noted above, this tissue ablation threshold can be exceeded if the energy is applied for too long a duration and/or too high a setting such that the tissue temperature rises or applied for too long a duration once the tissue temperature has reached the tissue ablation threshold before the flow of energy is terminated.
Also contributing to preventing overtreatment is to ensure the spacing between the electrodes in manufacture is precise so during application of energy, the amount of overlapping in a circumferential orientation is reduced. Such accurate and consistent spacing can also prevent undertreatment such as if the two of the circumferential array of electrodes are undesirably angled or curved too much toward each other, that would mean they are angled further away from the electrode on the opposite side, possibly creating a gap in the treatment in a circumferential orientation. The axial distance of the electrodes can also affect treatment. Therefore, maintaining the proper axial distance of the electrodes, preferably with the tips terminating at the same distal distance from the respective spine, and maintaining the proper radial distance of the tips, preferably evenly spaced along a circumference, will aid in maintaining the treatment between the lower threshold and maximum value threshold, i.e., between undertreatment and overtreatment.
The system, as noted above, also avoids ablating tissue due to careful and more accurate calibration of the tissue temperature measurement mechanism. This is basically achieved by precisely calibrating the PCB so it can read the voltage generated by the thermocouples more accurately, reducing the likelihood of heating tissue beyond the tissue ablation threshold. Thus, the PCB enables more accurate temperature measurements which in turn allows the system to disable or make the appropriate adjustment, e.g., increasing cooling fluid application, when the temperature limits are reached.
As discussed above, the centering of the needle pusher and attached electrodes, the alignment of the electrodes and the alignment of the basket arms provide maintain proper treatment zones to ensure the tissue is treated between the range of undertreatment and overtreatment. The suction disabling features discussed above also help to prevent overtreatment, i.e., ablation, of tissue.
While the above description contains many specifics, those specifics should not be construed as limitations on the scope of the disclosure, but merely as exemplifications of preferred embodiments thereof. Those skilled in the art will envision many other possible variations that are within the scope and spirit of the disclosure as defined by the claims appended hereto.

Claims

1-16. (canceled)

17. A method of treating gastrointestinal reflux disease comprising:

providing a treatment device having a plurality of electrodes and an assembly having a disabler for disabling aspiration through an aspiration tube extending within the device, the disabler having a first position to enable aspiration from a distal portion of the aspiration tube to a proximal portion of the aspiration tube, the disabler movable to a second position to disable aspiration to facilitate axial and rotational movement of the treatment device within tissue and to limit undesired movement of tissue which can cause overtreatment of tissue and tissue ablation;

applying radiofrequency energy to the plurality of electrodes to thermally treat tissue below a tissue ablation threshold and create a plurality of tissue lesions along axially spaced tissue levels within the upper gastrointestinal tract;

monitoring tissue temperature throughout the applying of radiofrequency energy; and

regulating power ensuring in response to the monitoring of tissue temperature that the tissue temperature does not exceed a predetermined value which would cause tissue ablation and/or tissue necrosis.

18. The method for claim 17, further comprising the step of sliding a mechanism to selectively cover and uncover an opening in a sidewall of the aspiration tube.

19. The method of claim 17, further comprising the step of moving a mechanism radially inwardly to deform a wall of the aspiration tube.

20. The method of claim 17, wherein the plurality of electrodes each have a non-penetrating tip substantially conical in configuration to deform the tissue when advanced into contact with tissue.

21. The method of claim 17, wherein in the first position an opening in the aspiration tube is closed to enable aspiration and in the second position the opening in the aspiration tube is open to disable aspiration.

22. The method of claim 21, wherein the opening is in a sidewall of the aspiration tube.

23. The method of claim 17, wherein the plurality of electrodes are maintained in axial alignment when advanced from the treatment device.

24. The method of claim 23, wherein tips of the plurality of electrodes are maintained at equidistant radial spacing when advanced from the treatment device.

25. The method of claim 17, wherein aspiration is disabled without having to shut off a vacuum.

26. The method of claim 17, wherein aspiration is disabled at a handle section of the treatment device.

27. A method of treating gastrointestinal reflux disease in a patient comprising:

providing a treatment device having an expandable basket assembly, a plurality of electrodes movable from a retracted position within the basket assembly to an extended position extending from the basket assembly and an assembly having a disabler for disabling aspiration through an aspiration tube, the disabler having a first position to enable aspiration from a distal portion of the aspiration tube to a proximal portion of the aspiration tube, the disabler movable to a second position to disable aspiration to facilitate axial and rotational movement of the treatment device within tissue and to limit undesired movement of tissue to prevent overtreatment and tissue ablation;

advancing the plurality of electrodes from the basket assembly;

applying radiofrequency energy to the plurality of electrodes to thermally treat tissue below a tissue ablation threshold and create a plurality of tissue lesions at a first tissue level of a plurality of axially spaced tissue levels within an upper gastrointestinal tract of the patient;

monitoring tissue temperature throughout the application of radiofrequency energy;

regulating power ensuring in response to the monitoring of tissue temperature that the tissue temperature does not exceed a predetermined value which would cause tissue ablation and/or tissue necrosis;

disabling aspiration while the vacuum remains on and subsequently moving the treatment device axially to a second tissue level of the axially spaced tissue levels, the disabling of aspiration releasing tissue which could otherwise be pulled to the second tissue level,

advancing the plurality of electrodes at the second tissue level; and

applying radiofrequency energy to the plurality of electrodes to thermally treat tissue at the second tissue level below a tissue ablation threshold and create a plurality of tissue lesions at the second tissue level within the upper gastrointestinal tract of the patient.

28. The method of claim 27, wherein the user can disable and enable aspiration at a handle region of the treatment device.

29. The method of claim 27, wherein disabling suction releases any tissue hugging the treatment device to avoid unwanted movement of tissue during axial movement of the device to treat a next axially spaced tissue level.

30. The method of claim 27, further comprising the step of locking the disabler in position.

31. The method of claim 27, wherein the plurality of electrodes are maintained in axial alignment by a spacer within the treatment device.

32. The method of claim 27, wherein the basket assembly includes a balloon collapsible for movement of the treatment device.

33. The method of claim 32, wherein aspiration is disabled at a handle section of the treatment device.